Elena Geretti

64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer

Helen Lee, Anthony F. Shields, Barry A. Siegel et al. · Clinical Cancer Research · 2017 · 359 citations · Full text

Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1

Elaine K. Lau, Chad D. Paavola, Zoë Johnson et al. · Journal of Biological Chemistry · 2004 · 201 citations · Full text

Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer

Christopher W. Espelin, Shannon C. Leonard, Elena Geretti et al. · Cancer Research · 2016 · 122 citations · Full text

Breast Oncology, Combined Mm-302/trastuzumab Therapy, Tumor Biology +16

Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study

Pamela N. Münster, Ian E. Krop, Patricia LoRusso et al. · British Journal of Cancer · 2018 · 117 citations · Full text

HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity

Joseph G. Reynolds, Elena Geretti, Bart S. Hendriks et al. · Toxicology and Applied Pharmacology · 2012 · 112 citations

Tumor Biology, Oncology, Anti-tumorigenic Effects +7